Co-Authors
This is a "connection" page, showing publications co-authored by Etienne Decroly and Bruno Coutard.
Connection Strength
1.801
-
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. 2020 04; 176:104742.
Score: 0.866
-
Drugs against SARS-CoV-2: What do we know about their mode of action? Rev Med Virol. 2020 11; 30(6):1-10.
Score: 0.224
-
In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication. Sci Rep. 2020 08 04; 10(1):13093.
Score: 0.224
-
Toward the identification of viral cap-methyltransferase inhibitors by fluorescence screening assay. Antiviral Res. 2017 08; 144:330-339.
Score: 0.181
-
Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2'-O-methyltransferase nsp10/nsp16 complex. PLoS Pathog. 2011 May; 7(5):e1002059.
Score: 0.118
-
Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2'O)-methyltransferase activity. J Virol. 2008 Aug; 82(16):8071-84.
Score: 0.095
-
Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis. Nat Commun. 2020 09 17; 11(1):4682.
Score: 0.056
-
SARS-CoV ORF1b-encoded nonstructural proteins 12-16: replicative enzymes as antiviral targets. Antiviral Res. 2014 Jan; 101:122-30.
Score: 0.035